Results 181 to 190 of about 555,637 (312)

Roles of RNA Structures in the Genome Translation of (+) Sense RNA Viruses. [PDF]

Viruses
Lu G, Beyene BG, Camacho JM, Koirala D.
europepmc   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon, Rui P. L. Neves, Nikolas H. Stoecklein, Sven‐Thorsten Liffers, Jens Siveke, Jan D. Kuhlmann, Pauline Wimberger, Paul Buderath, Rainer Kimmig, Sabine Kasimir‐Bauer   +9 more
wiley   +1 more source

Improvement of In Vitro Seed Germination and Shoot Development of the Indonesian Endangered Orchid, <i>Dendrobium lineale</i> Rolfe, Using Sucrose and Coconut Water. [PDF]

Scientifica (Cairo)
Utami ESW, Lestari S, Wahyuni DK, Junairiah, Purnobasuki H, Hariyanto S, Istighfari N, Murtadlo AAA, Umamah S.   +8 more
europepmc   +1 more source

On citing well [PDF]

Nature Chemical Biology, 2010
openaire   +2 more sources

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Molecular gatekeepers: eukaryotic translation factors decoding plant-virus dynamics for resistance engineering. [PDF]

Stress Biol
Singhal P, Saini S, Saini O, Bishnoi A, E R R, Meena BR, Singh J, Yogendra K.   +7 more
europepmc   +1 more source

Leipzig Charter on Sustainable European Cites - A Work in Progress [PDF]

, 2010
Eltges, Markus
core   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source

Barriers Implementing Patient-Specific 3D-Printed Bone Scaffolds in Australia: A Scoping Review. [PDF]

Int J Biomater
Vidler A, Hayes A.
europepmc   +1 more source

Cites & Insights

netbib, 2006
openaire   +2 more sources